1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Diabetic Foot Ulcer Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Diabetic Foot Ulcer Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Diabetic Foot Ulcer Market Regional Analysis
6.2 Europe Diabetic Foot Ulcer Market Revenue 2020-2030 (US$ Million)
6.3 Europe Diabetic Foot Ulcer Market Forecast Analysis
7. Europe Diabetic Foot Ulcer Market Analysis – by Ulcer Type
7.1 Neuropathic Ulcers
- 7.1.1 Overview
- 7.1.2 Neuropathic Ulcers: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Ischemic Ulcers
- 7.2.1 Overview
- 7.2.2 Ischemic Ulcers: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Neuro-ischemic Ulcers
- 7.3.1 Overview
- 7.3.2 Neuro-ischemic Ulcers: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Diabetic Foot Ulcer Market Analysis – by Treatment Type
8.1 Advanced Wound Care Dressings
- 8.1.1 Overview
- 8.1.2 Advanced Wound Care Dressings: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Biologics
- 8.2.1 Overview
- 8.2.2 Biologics: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Therapy Device
- 8.3.1 Overview
- 8.3.2 Therapy Device: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Diabetic Foot Ulcer Market Analysis – by Infection Severity
9.1 Moderate
- 9.1.1 Overview
- 9.1.2 Moderate: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Mild
- 9.2.1 Overview
- 9.2.2 Mild: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Severe
- 9.3.1 Overview
- 9.3.2 Severe: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Diabetic Foot Ulcer Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Ambulatory Surgery Centers
- 10.2.1 Overview
- 10.2.2 Ambulatory Surgery Centers: Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Home Care
- 10.3.1 Overview
- 10.3.2 Home Care : Europe Diabetic Foot Ulcer Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Europe Diabetic Foot Ulcer Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Diabetic Foot Ulcer Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Europe Diabetic Foot Ulcer Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 UK:
Europe Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 UK: Europe Diabetic Foot Ulcer Market Breakdown, by Ulcer Type
- 11.2.1.1.2 UK: Europe Diabetic Foot Ulcer Market Breakdown, by Treatment Type
- 11.2.1.1.3 UK: Europe Diabetic Foot Ulcer Market Breakdown, by Infection Severity
- 11.2.1.1.4 UK: Europe Diabetic Foot Ulcer Market Breakdown, by End User
- 11.2.1.2 Germany:
Europe Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Germany: Europe Diabetic Foot Ulcer Market Breakdown, by Ulcer Type
- 11.2.1.2.2 Germany: Europe Diabetic Foot Ulcer Market Breakdown, by Treatment Type
- 11.2.1.2.3 Germany: Europe Diabetic Foot Ulcer Market Breakdown, by Infection Severity
- 11.2.1.2.4 Germany: Europe Diabetic Foot Ulcer Market Breakdown, by End User
- 11.2.1.3 France:
Europe Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 France: Europe Diabetic Foot Ulcer Market Breakdown, by Ulcer Type
- 11.2.1.3.2 France: Europe Diabetic Foot Ulcer Market Breakdown, by Treatment Type
- 11.2.1.3.3 France: Europe Diabetic Foot Ulcer Market Breakdown, by Infection Severity
- 11.2.1.3.4 France: Europe Diabetic Foot Ulcer Market Breakdown, by End User
- 11.2.1.4 Russia:
Europe Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Russia: Europe Diabetic Foot Ulcer Market Breakdown, by Ulcer Type
- 11.2.1.4.2 Russia: Europe Diabetic Foot Ulcer Market Breakdown, by Treatment Type
- 11.2.1.4.3 Russia: Europe Diabetic Foot Ulcer Market Breakdown, by Infection Severity
- 11.2.1.4.4 Russia: Europe Diabetic Foot Ulcer Market Breakdown, by End User
- 11.2.1.5 Italy:
Europe Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Italy: Europe Diabetic Foot Ulcer Market Breakdown, by Ulcer Type
- 11.2.1.5.2 Italy: Europe Diabetic Foot Ulcer Market Breakdown, by Treatment Type
- 11.2.1.5.3 Italy: Europe Diabetic Foot Ulcer Market Breakdown, by Infection Severity
- 11.2.1.5.4 Italy: Europe Diabetic Foot Ulcer Market Breakdown, by End User
- 11.2.1.6 Rest of Europe:
Europe Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Diabetic Foot Ulcer Market Breakdown, by Ulcer Type
- 11.2.1.6.2 Rest of Europe: Europe Diabetic Foot Ulcer Market Breakdown, by Treatment Type
- 11.2.1.6.3 Rest of Europe: Europe Diabetic Foot Ulcer Market Breakdown, by Infection Severity
- 11.2.1.6.4 Rest of Europe: Europe Diabetic Foot Ulcer Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Convatec Group Plc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 3M Co
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Coloplast AS
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Smith & Nephew Plc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 B. Braun SE
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Medline Industries LP
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Organogenesis Inc.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Mölnlycke Health Care AB
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 MiMedx Group Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations